Teva Pharmaceuticals USA, Inc. recalls CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVA PHARMACE
Recalled April 10, 2013 · FDA recall D-237-2013 · Teva Pharmaceuticals USA
Hazard
Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity. · FDA Class II
Units
3 boxes
Sold at
NC
Description
Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.
Product
CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVA PHARMACEUTICALS USA, Sellersville PA 18960, NDC #0555-0096-96
Manufacturer(s)
Teva Pharmaceuticals USA, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →